Thorne Magnesium Bisglycinate review: is it worth it?

What is Thorne Magnesium Bisglycinate and who makes it?

Thorne Magnesium Bisglycinate is a powdered dietary supplement made by Thorne (formerly Thorne Research), a U.S. supplement company founded in 1984 and known for clinician-facing, single-ingredient formulas. The product contains one active ingredient: magnesium as magnesium bisglycinate — magnesium bound to two molecules of the amino acid glycine. One level scoop (about 4 grams of powder) provides 200 mg of elemental magnesium, and a jar contains 60 servings. The powder is lightly sweetened with monk fruit and flavored with a hint of citrus, and is designed to dissolve in water.

The label positions it for "restful sleep, muscle relaxation, heart health, and metabolism" — standard structure/function claims that, like all supplements, are not evaluated by the FDA for disease treatment. What sets the product apart on paper is quality assurance rather than a unique formula: it is NSF Certified for Sport, meaning each batch is tested against roughly 290 substances banned in competitive athletics and verified to match its label (NSF). For consumers who can't physically inspect a factory, that certification is a meaningful signal of identity and purity in an industry where independent testing repeatedly finds mislabeled products.

"Bisglycinate" and "glycinate" refer to the same chemistry; Thorne also sells a capsule "Magnesium Glycinate." The powder reviewed here is the bisglycinate version. There is nothing proprietary about magnesium bisglycinate — many brands sell it — so you are paying for Thorne's sourcing, testing, and a clean ingredient list, not a patented compound.

How does magnesium work for sleep and muscle relaxation?

Magnesium is an essential mineral and a cofactor for more than 300 enzymatic reactions in the body, including those governing energy (ATP) production, protein synthesis, blood glucose control, blood pressure regulation, and nerve and muscle function (NIH Office of Dietary Supplements). Its relevance to sleep and relaxation rests on a few plausible mechanisms rather than a single proven pathway:

• NMDA and GABA modulation. Magnesium acts as a natural blocker at NMDA (glutamate) receptors and supports GABA activity. Glutamate is excitatory; GABA is the brain's main calming neurotransmitter. In theory, adequate magnesium nudges the nervous system toward "rest."
• Neuromuscular function. Magnesium counterbalances calcium at the neuromuscular junction. Low magnesium can contribute to muscle excitability and cramping, which is why it is associated with relaxation.
• Stress-axis effects. Magnesium status interacts with the HPA (stress) axis and cortisol regulation.

The role of the glycine carrier is sometimes oversold. Glycine itself is an inhibitory neurotransmitter and has its own small sleep literature, but the amount of glycine delivered by a magnesium bisglycinate dose is far below the 3-gram doses used in glycine sleep studies. In bisglycinate, glycine's main practical job is acting as a chelating "shuttle" that improves absorption and reduces the laxative effect — not delivering a separate sleep drug.

Crucially, these mechanisms explain why correcting a *deficiency* could improve sleep. They do not establish that extra magnesium acts as a sedative in people who already have adequate levels. That distinction is the heart of the evidence question below.

What does magnesium bisglycinate as a form add — and does it matter?

The bisglycinate form's selling point is absorption and tolerability, not a special sleep effect. The evidence here is reasonably consistent:

• Inorganic magnesium oxide — the cheapest and most common form in mass-market supplements — is poorly soluble and poorly absorbed. Organic and chelated forms (citrate, amino-acid chelates such as glycinate) dissolve more readily and are absorbed more efficiently. A randomized, double-blind trial found organic magnesium forms produced significantly greater absorption than oxide measured by urinary excretion after 60 days (PMID 14596323).
• A small study in patients with ileal resection (impaired absorption) found magnesium diglycinate was absorbed via a dipeptide transport pathway, suggesting chelated glycinate may use an alternative route that bypasses some competition (PMID 7815675).
• Clinically, glycinate is widely regarded as gentler on the gut than oxide or citrate, producing less osmotic diarrhea at a given dose — which matters because GI upset is the main reason people abandon magnesium.

The honest caveat: head-to-head human trials proving glycinate is *superior to citrate* specifically for sleep do not really exist. What you can say with confidence is that bisglycinate is well absorbed and well tolerated. Whether it outperforms a much cheaper magnesium citrate for the purpose of sleep is not established by direct evidence.

Does it actually work for sleep? What the trials show

This is where independence matters, because the category is heavily marketed. The most relevant recent evidence:

A 2025 randomized, placebo-controlled trial (Schuster et al., *Nature and Science of Sleep*, 2025) is the best-designed test of this exact form. It was a four-week, double-blind, parallel-group study in 155 adults with self-reported poor sleep. Participants took either 250 mg elemental magnesium as bisglycinate nightly or placebo. The magnesium group's Insomnia Severity Index (ISI) fell by 3.9 points versus 2.3 points for placebo — a difference that was statistically significant but small (p = 0.049; Cohen's d ≈ 0.2). Notably, an exploratory analysis found that people with lower baseline dietary magnesium intake responded more (Spearman's rho = −0.25, p = 0.036), hinting that the benefit is concentrated in those who were under-consuming magnesium to begin with.

A 2021 systematic review and meta-analysis of oral magnesium for insomnia in older adults (PMID 33865376; *BMC Complementary Medicine and Therapies*) pooled three randomized trials in 151 participants. It found sleep onset latency was about 17 minutes shorter with magnesium versus placebo. But the authors explicitly rated the trials at moderate-to-high risk of bias and graded the overall evidence low to very low quality — meaning the true effect is uncertain and could be smaller.

Putting it together: the most defensible conclusion is that magnesium probably produces a small, real improvement in subjective sleep for some people — likely largest in those with low magnesium intake or marginal deficiency — but it is not a reliable, sedative-strength sleep aid for everyone. Anyone expecting an effect comparable to a prescription hypnotic will be disappointed. As an independent reviewer, we would describe it as a low-risk option with modest, inconsistent benefit, not a proven insomnia treatment.

Who is it best for — and who should skip it?

Likely to benefit:

• People with low dietary magnesium intake — common given that a substantial share of U.S. adults consume less than the estimated requirement (NIH).
• People with conditions or medications that deplete magnesium: type 2 diabetes, chronic alcohol use, long-term proton-pump inhibitor (PPI) use, loop or thiazide diuretics, and GI disorders that impair absorption (NIH).
• Athletes and people who want a banned-substance-tested product, where NSF Certified for Sport is genuinely useful.
• Those who got GI upset from cheaper magnesium oxide or citrate and want a gentler form.

Who should skip it or check with a clinician first:

• People with reduced kidney function or kidney failure. Impaired kidneys cannot clear excess magnesium, raising the risk of dangerous hypermagnesemia. This is the single most important contraindication (NIH).
• People already getting adequate magnesium from diet, who are unlikely to notice a sleep effect.
• Anyone treating genuine insomnia who expects a supplement to replace evaluation of underlying causes (sleep apnea, anxiety, poor sleep hygiene). Cognitive behavioral therapy for insomnia (CBT-I) is the guideline-recommended first-line treatment, not a mineral.
• People taking certain medications (see interactions below).

Side effects, safety, and interactions

For healthy adults, supplemental magnesium has a strong safety profile, but it is not side-effect-free. The most common problem is gastrointestinal: loose stools, diarrhea, nausea, and abdominal cramping. The bisglycinate form is among the least likely to cause this, but high doses can still loosen stools.

The NIH sets a Tolerable Upper Intake Level (UL) of 350 mg per day for magnesium from supplements (this UL applies to supplemental magnesium only, not magnesium from food, which has no upper limit because the kidneys excrete dietary excess). At 200 mg per scoop, a single serving sits comfortably under that limit; two scoops (400 mg) exceeds the supplemental UL and is more likely to cause diarrhea. The RDA from all sources is 400–420 mg/day for men and 310–320 mg/day for women (NIH).

Serious toxicity (hypermagnesemia) — causing low blood pressure, lethargy, confusion, irregular heartbeat, and in extreme cases cardiac arrest — is essentially confined to people with impaired kidney function or those taking very large doses (NIH). Healthy kidneys protect against it.

Drug interactions to know (NIH):

• Bisphosphonates (e.g., alendronate for osteoporosis): magnesium reduces their absorption — separate doses by at least 2 hours.
• Certain antibiotics (tetracyclines like doxycycline, and quinolones like ciprofloxacin): magnesium binds them and reduces effectiveness — separate by 2–4 hours.
• Diuretics: loop and thiazide diuretics increase magnesium loss; potassium-sparing diuretics can raise magnesium.
• PPIs: long-term use is associated with low magnesium.

Pregnant or breastfeeding people and anyone with kidney disease, heart block, or on the medications above should consult a clinician before use.

How to take it: dosing and timing

The label directs mixing one level scoop (≈4 g, 200 mg elemental magnesium) in 8 oz of water, once or twice daily, with evening dosing suggested for sleep and recovery. A practical, evidence-aligned approach:

• Start with one scoop (200 mg) in the evening, 30–60 minutes before bed. This keeps you within the supplemental UL and lets you assess GI tolerance.
• The sleep trial above used 250 mg nightly, so a single 200 mg scoop is in a reasonable range; you do not need two scoops for the sleep use case, and 400 mg/day exceeds the supplemental UL.
• Take it consistently for at least 3–4 weeks before judging it — benefits in trials accrued over weeks, not on the first night.
• If you take bisphosphonates or the antibiotics noted above, separate dosing by several hours.
• Powder vs. capsule is a convenience choice; the powder allows flexible dosing and may be easier for those who dislike pills.

Cost and value

Thorne Magnesium Bisglycinate is priced as a premium product. At representative retail it runs from roughly $30 to around $50 for a 60-serving jar depending on retailer — roughly $0.50 to $0.85 per 200 mg serving. That is several times the cost of generic magnesium glycinate or magnesium oxide. (Prices change frequently and vary by retailer, so check current listings before buying.)

The value question is honest: the *magnesium* is not better than cheaper bisglycinate from a reputable maker. What the premium buys is third-party verification (NSF Certified for Sport), a clean single-ingredient powder with no unnecessary fillers, and Thorne's quality reputation. For an athlete subject to drug testing, that certification alone can justify the price. For a general consumer simply wanting more magnesium, a less expensive USP-verified or NSF-certified glycinate delivers the same active ingredient for less.

How it compares to alternatives

• vs. magnesium oxide (mass-market, cheapest): oxide is poorly absorbed and more laxative per mg of *absorbed* magnesium. Bisglycinate is clearly the better-tolerated, better-absorbed choice for daily use.
• vs. magnesium citrate: citrate is well absorbed and cheaper, but more likely to loosen stools (it's used as a laxative). For sleep, no trial proves glycinate beats citrate; glycinate's edge is GI comfort.
• vs. magnesium L-threonate (marketed for brain/cognition): threonate is far more expensive and its cognitive claims rest largely on animal and small human data; for sleep specifically there is no strong reason to pay more.
• vs. "magnesium for sleep" blends (with melatonin, L-theanine, etc.): blends may feel more effective due to the melatonin, but they muddy what's actually working and often under-dose magnesium. A single-ingredient product like Thorne's is cleaner for isolating effect.
• vs. melatonin: different mechanism; melatonin targets sleep timing and has more direct (if modest) trial support for sleep onset. The two are sometimes combined, but that is a separate decision.

The bottom line

Thorne Magnesium Bisglycinate is a high-quality, honestly formulated, third-party-tested magnesium supplement in a well-absorbed, gentle form. If you have low magnesium intake or want a clean, banned-substance-tested source, it is a reasonable, low-risk choice — and the best current trial (Schuster 2025) suggests a small but real improvement in subjective sleep over four weeks, especially for people who were low in magnesium to begin with. But set expectations accordingly: the overall evidence base is graded low quality, the effect is modest, and magnesium is not a substitute for treating the actual causes of poor sleep. The main downsides are price (you pay a premium largely for certification, not for better magnesium) and the fact that anyone with kidney impairment should avoid it. As an independent assessment: a sensible, safe supplement to *try* for a month if you suspect low magnesium — not a guaranteed fix for insomnia, and not worth the premium over a comparable certified glycinate unless the NSF Certified for Sport status matters to you.

*This article is for educational purposes and is not medical advice. Talk to a qualified clinician before starting any supplement, especially if you have kidney disease, take prescription medication, or are pregnant or breastfeeding.*